ClariVest Asset Management’s Karyopharm Therapeutics KPTI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,973	Closed	-$440K	–	725
2022 Q1	$440K	Buy	+3,973	New	+$440K	0.02%	405